Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sayan Chakraborty

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 13, 2018
Heterodimer formation by Oct4 and Smad3 differentially regulates epithelial-to-mesenchymal transition-associated factors in breast cancer progressionGunjan Mandal, Subir Biswas, Sougata Roy Chowdhury, et al.
Nature Communications|November 4, 2021
Agrin-Matrix Metalloproteinase-12 axis confers a mechanically competent microenvironment in skin wound healingSayan Chakraborty, Divyaleka Sampath, Melissa Ong Yu Lin, et al.
Biomolecules|September 27, 2025
A Comprehensive Oncological Biomarker Framework Guiding Precision MedicineReza Bayat Mokhtari, Manpreet Sambi, Faezeh Shekari, et al.
ACS Chemical Biology|November 20, 2019
Identification of Quinolinols as Activators of TEAD-Dependent TranscriptionAjaybabu V Pobbati, Tom Mejuch, Sayan Chakraborty, et al.
Journal of Medicinal Chemistry|May 23, 2026
Mitigating Excessive Mitochondrial Fission Through the Development of a Selective Macrocyclic Inhibitor Targeting Fis1/Mid51 SignalingMulate Zerihun, Sayan Chakraborty, Ayetenew Abita, et al.
ACS Medicinal Chemistry Letters|March 18, 2026
Discovery of Pan-TEAD Inhibitors That Disrupt YAP-TEAD Interaction as a Potential Therapy for Gastric Cancers and Mutant KRAS and EGFR Lung CancersRamesh Kumar, Joanne Thian, Joel D W Toh, et al.
European Journal of Medicinal Chemistry|October 30, 2025
Allosteric inhibition of JAK2 with lysine-reactive compounds that bind the pseudokinase domainMarina C Primi, Maurício T Tavares, John M Hatcher, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
RAF isoform selectivity of MEK inhibitors and rational design of a covalent ARAF-MEK inhibitorSayan Chakraborty, Jie Jiang, Javier Vinals Camallonga, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 1, 2025
An Agrin-YAP/TAZ Rigidity Sensing Module Drives EGFR-Addicted Lung TumorigenesisReza Bayat Mokhtari, Divyaleka Sampath, Paige Eversole, et al.
Drug Discoveries & Therapeutics|November 1, 2021
Post COVID-19 sequelae: A prospective observational study from Northern IndiaShivdas Naik, Soumendra Nath Haldar, Manish Soneja, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 13, 2018
Heterodimer formation by Oct4 and Smad3 differentially regulates epithelial-to-mesenchymal transition-associated factors in breast cancer progressionGunjan Mandal, Subir Biswas, Sougata Roy Chowdhury, et al.
Nature Communications|November 4, 2021
Agrin-Matrix Metalloproteinase-12 axis confers a mechanically competent microenvironment in skin wound healingSayan Chakraborty, Divyaleka Sampath, Melissa Ong Yu Lin, et al.
Biomolecules|September 27, 2025
A Comprehensive Oncological Biomarker Framework Guiding Precision MedicineReza Bayat Mokhtari, Manpreet Sambi, Faezeh Shekari, et al.
ACS Chemical Biology|November 20, 2019
Identification of Quinolinols as Activators of TEAD-Dependent TranscriptionAjaybabu V Pobbati, Tom Mejuch, Sayan Chakraborty, et al.
Journal of Medicinal Chemistry|May 23, 2026
Mitigating Excessive Mitochondrial Fission Through the Development of a Selective Macrocyclic Inhibitor Targeting Fis1/Mid51 SignalingMulate Zerihun, Sayan Chakraborty, Ayetenew Abita, et al.
ACS Medicinal Chemistry Letters|March 18, 2026
Discovery of Pan-TEAD Inhibitors That Disrupt YAP-TEAD Interaction as a Potential Therapy for Gastric Cancers and Mutant KRAS and EGFR Lung CancersRamesh Kumar, Joanne Thian, Joel D W Toh, et al.
European Journal of Medicinal Chemistry|October 30, 2025
Allosteric inhibition of JAK2 with lysine-reactive compounds that bind the pseudokinase domainMarina C Primi, Maurício T Tavares, John M Hatcher, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
RAF isoform selectivity of MEK inhibitors and rational design of a covalent ARAF-MEK inhibitorSayan Chakraborty, Jie Jiang, Javier Vinals Camallonga, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 1, 2025
An Agrin-YAP/TAZ Rigidity Sensing Module Drives EGFR-Addicted Lung TumorigenesisReza Bayat Mokhtari, Divyaleka Sampath, Paige Eversole, et al.
Drug Discoveries & Therapeutics|November 1, 2021
Post COVID-19 sequelae: A prospective observational study from Northern IndiaShivdas Naik, Soumendra Nath Haldar, Manish Soneja, et al.
Pageof 8